| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18832520 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 101 journal articles in the PubMed database | Email to a friend | | |
| Kruis W, Kiudelis G, Racz I, et al.
Once-daily versus three-times-daily mesalazine granules in active ulcerative colitis: A double-blind, double-dummy, randomised non-inferiority trial. [JOURNAL ARTICLE]
Gut 2008 Oct 2.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Kruis W, Schreiber S, Theuer D, et al.
Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Gut 2001 Dec; 49(6):783-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Ardizzone S, Doldo P, Ranzi T, et al.
Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group. [Clinical Trial, Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial]
Ital J Gastroenterol Hepatol 1999 Nov; 31(8):677-84.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Vecchi M, Meucci G, Gionchetti P, et al.
Oral versus combination mesalazine therapy in active ulcerative colitis: a double-blind, double-dummy, randomized multicentre study. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Aliment Pharmacol Ther 2001 Feb; 15(2):251-6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Tytgat GN, Van Nueten L, Van De Velde I, et al.
Efficacy and safety of oral ridogrel in the treatment of ulcerative colitis: two multicentre, randomized, double-blind studies. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Aliment Pharmacol Ther 2002 Jan; 16(1):87-99.
Abstract | Full Citation | Find Related Articles | | D'Haens G, Hommes D, Engels L, et al.
Once daily MMX mesalazine for the treatment of mild-to-moderate ulcerative colitis: a phase II, dose-ranging study. [Journal Article]
Aliment Pharmacol Ther 2006 Oct 1; 24(7):1087-97.
Abstract | Full Citation | Find Related Articles | | Rachmilewitz D
Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
BMJ 1989 Jan 14; 298(6666):82-6.
Abstract | Full Citation | Find Related Articles | | Pokrotnieks J, Marlicz K, Paradowski L, et al.
Efficacy and tolerability of mesalazine foam enema (Salofalk foam) for distal ulcerative colitis: a double-blind, randomized, placebo-controlled study. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Aliment Pharmacol Ther 2000 Sep; 14(9):1191-8.
Abstract | Full Citation | Find Related Articles | | Biancone L, Gionchetti P, Blanco GD, et al.
Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: A multicenter, randomized, double-blind study. [JOURNAL ARTICLE]
Dig Liver Dis 2007 Mar 6.
Abstract | Full Citation | Find Related Articles |   |
|
| |
Advertise on this site.
|
